# Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Knee Degenerative Osteoarthritis

> **NCT05917028** · NA · RECRUITING · sponsor: **Next Biomedical Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DEVICE:** Transcatheter Arterial Micro-Embolization

## Key facts

- **NCT ID:** NCT05917028
- **Lead sponsor:** Next Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-23
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05917028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05917028, "Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Knee Degenerative Osteoarthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05917028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*